Trial intelligence / Profile preview

Lavender Essential Oil Formulation for Androgenic Alopecia

IRCT20241015063373N1Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of lavender oil in androgenetic alopecia (AGA), sponsored by Tabriz University of Medical Sciences. Started Oct 2024; status: completed.

02

Drugs

lavender oil
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on IRCT20241015063373N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20241015063373N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call